Semble

Name: Semble
Brand: Semble
Rating: 4.6 (24 reviews)

Semble is a private healthcare practice management and EHR/EMR platform that consolidates patient records, appointments, clinical documentation, communications, prescribing/lab/referrals and invoicing/payments into a single system and exposes a public GraphQL API plus an integrations layer for interoperability.

Est 2015|Valuation $160.8M|35 Ref Customers

LinkedIn 8K|Web traffic 881K|FTEs 144|HQ London, United Kingdom

Published Oct 13, 2026

01Common complaints

- If transparent, self-serve pricing is required - Vendor materials accessed in this research pass did not provide a definitive public price list; buyers seeking immediate, self-serve price clarity may prefer vendors that publish tiered pricing. - If operational continuity depends on guaranteed high-touch support - Public review material includes at least one report describing severely deficient support. Organizations with minimal internal IT buffer and high sensitivity to vendor responsiveness should verify SLA and support commitments before procurement. - If integrations and platform extensibility are not needed - Semble’s product positioning emphasizes integrations and API extensibility; organizations with simple booking and invoicing needs may find simpler, lower-cost solutions more appropriate. - If specific certifications or enterprise controls are required but not publicly documented - ISO 27001 is referenced in vendor materials; other certifications and specific enterprise controls (SSO/SCIM, SOC 2 scope) were not clearly documented in the retrieved excerpts. Buyers with strict compliance checklists should request documentation via the vendor Trust Center and security questionnaires. - Current limitations acknowledged by the vendor - API access may be restricted by package or role; this indicates possible gating of some integration capabilities depending on buyer entitlements. - Features on the roadmap (not yet available) - Vendor materials reference planned integrations such as imaging/diagnostic tools and marketing capabilities; no definitive timelines were provided in the retrieved excerpts. - Scale limitations - No public, quantitative scale limitations were identified in the sources retrieved for this research pass. - Security or compliance gaps - ISO 27001 and UK/EU hosting claims are documented; some enterprise controls and additional certifications commonly requested by large purchasers (e.g., detailed SOC 2 scope, ISO 27017/27018) were not explicitly documented in the materials retrieved. - API limitations or integration constraints - The GraphQL API supports flexible queries but may require specific developer expertise compared with simpler REST-based integrations. - Partner integrations are curated; some integrations will require custom development effort.

Deal disqualifiers: characteristics of a poor fit

Organizations requiring extensive third-party validation via broad review volume and widely published independent case studies; review volume for Semble is limited on some platforms.
Organizations that require consistently high-touch technical support as an absolute requirement, given some public complaints about support responsiveness.

Why some customers left for competitors (churn reasons)

No clear, documented churn narratives were found in the accessible sources for this research pass.

02Why they buy

- Customer-reported benefits - Reviews and user feedback emphasize consolidation of clinical and operational workflows into a single system and reduced need to switch between tools. - Product differentiation based on available evidence - Public GraphQL API and platform framing: Semble provides a public GraphQL API intended for integrating with existing systems and building healthcare applications on top of the EHR layer. - Areas where competitors have advantages - Review depth: Competitors with more extensive review footprints provide more buyer confidence via larger sample sizes and more documented customer outcomes.

03Field reports

Review platform availability note

Attempts to locate Semble product reviews on several enterprise review platforms returned mixed results: some platforms had Semble listings with limited review volume; others did not yield Semble-specific pages in this research pass.

Summarized review content from accessible platforms

- A G2 review written in Italian reports that Semble reduced the need to switch between tools and simplified clinical workflows, indicating perceived consolidation of records, appointments, notes, and communications. - Capterra reviews contained both positive and negative feedback: one review highlighted benefits for online booking and accessible pre-consultation forms; another reviewer reported very poor technical support. - Vendor-published testimonial material (Murakami Medical Centre) reports faster completion of lab reports following integration with Semble; this is vendor-provided content and the metric and causal attribution were not independently validated.

Community / social discussion (note on relevance)

Community results retrieved during this research pass were primarily about a different product named "Semble" (an open-source code search tool) and are not evidence about the healthcare software; therefore community sentiment specific to the healthcare product is limited in this research pass.

Common criticisms and complaints (from accessible reviews)

A notable negative datapoint from a public review source describes technical support as effectively unavailable; the frequency of support complaints could not be quantified from the available sample.
Review volume on some platforms is limited, reducing confidence in generalizing sentiment across the customer base.

Why customers reportedly chose the product over alternatives (inferred from review themes)

Buyers cited consolidation of multiple clinic functions into a single system and an integration-forward approach (API and partner integrations) as reasons to evaluate Semble.

Specific outcomes customers reported (with metrics when available)

Vendor-published material reports reduced lab-report turnaround times; independent verification or methodological detail (baseline, sample size, time window) was not available.

Deal-breakers and reasons customers did not purchase

Not comprehensively documented in the retrieved sources. Typical category deal-breakers that apply based on observed signals include support responsiveness and the complexity/cost of integrations and migration.

Vendor-published case-style outcome

A vendor-published case reference reports that a clinic achieved faster lab report completion attributed to Semble's lab integrations.
Critical evaluation
- Attribution risk: Improvements attributed to the integration may also be influenced by lab operational SLAs, clinic workflows, and staffing.
- Methodology gap: The case material does not provide baseline metrics, sample size, measurement period, or independent verification.

Additional case study material

No independently published, detailed third-party case studies for Semble (healthcare) were located in the reviewed sources during this research pass.

04Best fit

Company sizes: specific employee counts and revenue ranges

- Suggested fit (inferred) - Small to mid-sized private clinics and growing multi-disciplinary practices that: - Require an EHR combined with scheduling, clinical notes, communications and wish to standardize workflows. - Have sufficient operational complexity to benefit from integrations (labs/pharmacy/finance) or API-based extensions. - Evidence limits - Review platform samples indicate usage by very small organizations and small businesses; broad usage patterns were not confirmed.

Industries and verticals where adoption is strongest

Private healthcare clinics in the UK are the primary target signals; the vendor references support for multiple medical specialties.

Roles and personas: decision makers AND end users

Practice managers and clinic operations staff responsible for workflows and administration.
Clinicians who document care and coordinate follow-ups.
IT staff or developers responsible for integrations and operational automation.

Pain points and challenges the product addresses

Reduction of tool sprawl and the need to switch between multiple systems.
Integration of prescribing, labs, referrals, and audit/reporting workflows suited to private clinic operations.
Access to data and interoperability via a public API.

Qualification criteria: characteristics of a strong fit

Organizations seeking an integrated EHR and practice operations core with the ability to connect external systems (labs, finance systems, AI scribe, etc.) and to extend functionality through an API.
Organizations operating in the UK/EU that value explicit data residency claims and ISO 27001 signaling.

05The pitch

What the product does (core value proposition in objective terms)

Semble is a private healthcare–focused practice management and EHR/EMR platform intended to consolidate core clinic workflows (patient records, appointments, clinical notes, communications, prescribing/labs/referrals via partners, invoicing/payments, and reporting) within a single system.
The product emphasizes interoperability: Semble offers a public GraphQL API and an integrations layer (Semble Connect) for connecting third-party clinical and business tools.

Target market and market positioning

The primary market signal is UK private healthcare providers and clinics (ranging from solo practices to multi-site, multi-disciplinary clinics) seeking a modern EHR combined with operational tooling and integrations for labs, pharmacies, and finance systems.
Market categorization and review listings place Semble in the patient management software, practice management, and EHR/EMR categories.

Get a comprehensive analysis of Semble including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →